by 
The Automated Cell Counters Market is estimated to be valued at US$ 3.75 Bn in 2023 and is expected to exhibit a CAGR of 7.0% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Automated cell counters are laboratory analytical instruments used for counting and analyzing cells present in blood, urine, and other body fluids. The instruments automate the manual process of cell counting and provide analytical results with high precision and accuracy. Automated cell counters use techniques like flow cytometry, electrical impedance, and light scattering to count and categorize cells based on predefined parameters like cell size, shape, granularity, and internal complexity. These systems provide fast, reliable, and reproducible analysis of cells and help save time and laboratory resources compared to manual methods.
Market Dynamics:
Increasing prevalence of chronic and infectious diseases is a major factor driving the growth of the automated cell counters market. Rising incidence of cancer, HIV/AIDS, cardiovascular diseases requiring routine cell analysis will boost the demand for automated cell counters. Technological advancements are also fueling market growth. Manufacturers are focusing on developing advanced cell counters with improved accuracy, high-throughput capabilities, integrated workflow solutions and data management systems. Additionally, growing number of approved cell-based therapy products is also propelling the automated cell counters market growth. However, high cost of advanced automated cell counters remains a major challenge.
Segment Analysis
The automated cell counters market can be segmented into single-platform cell counters and multi-platform cell counters. The multi-platform cell counters segment is dominating the market as they offer simultaneous analysis and counting of multiple cell types. They can analyze CD markers, viability staining and morphological parameters on different cell populations at the same time, which single-platform cell counters cannot do.
PEST Analysis
Political: Regulations regarding cell research and clinical trials are driving demand for automated cell counters for accurate analysis.
Economic: The growing biotechnology and pharmaceutical industries are investing heavily in R&D, thus boosting spending on automated lab equipment like cell counters.
Social: Rising incidence of diseases is increasing focus on development of advanced therapies based on stem cells and immunotherapies, fuelling need for cell analysis tools.
Technological: Introduction of novel techniques like microfluidics, artificial intelligence and cloud connectivity in cell counters is enhancing efficiency, speed, accuracy and affordability.
Key Takeaways
The global automated cell counters market is expected to witness high growth, exhibiting CAGR of 7.0% over the forecast period, due to increasing R&D spending in life science research. The market size for 2023 is estimated to be US$ 3.75 Bn.
North America is expected to dominate the market during the forecast period owing to presence of major players and advanced research infrastructure in the region. Asia Pacific is anticipated to be the fastest growing market due to rising healthcare expenditure, growing biopharmaceutical industry and increasing government funding for research.
Key players operating in the automated cell counters market are Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, PerkinElmer Inc., Bio-Rad Laboratories, BD, Merck KGaA, Logos Biosystems, Corning Incorporated, Tecan. These players are focusing on new product launches, partnerships, and expansions to increase their market share in this lucrative market.
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
